Home Stock

Stock Research: Apex Biotechnology

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Apex Biotechnology

TSEC:1733 TW0001733004
86
  • Value
    68
  • Growth
    87
  • Safety
    Safety
    63
  • Combined
    90
  • Sentiment
    82
  • 360° View
    360° View
    86
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

APEX BIOTECHNOLOGY CORP develops, manufactures, and distributes testing strips and monitoring systems. The company operates in the medical devices and diagnostics industries. It primarily serves markets in the Americas, Europe, and Asia. In the last fiscal year, the company had a market cap of $93 million, profits of $16 million, and revenue of $56 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 86 (better than 86% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Apex Biotechnology are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Apex Biotechnology. The consolidated Value Rank has an attractive rank of 63, which means that the share price of Apex Biotechnology is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 63% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 87, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 68. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 82. ...read more

more
Country Taiwan
Industry Health Care Equipment
Size X-Small
Website apexbio.com.tw
Index
FTSE Taiwan
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
63 45 66 77
Growth
87 8 47 45
Safety
Safety
68 58 65 37
Sentiment
82 93 93 68
360° View
360° View
86 44 96 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
15 15 18 18
Opinions Change
50 50 50 50
Pro Holdings
n/a 76 100 85
Market Pulse
100 100 100 100
Sentiment
82 93 93 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
63 45 66 77
Growth
87 8 47 45
Safety Safety
68 58 65 37
Combined
90 20 63 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
50 20 39 56
Price vs. Earnings (P/E)
62 60 59 74
Price vs. Book (P/B)
38 40 45 64
Dividend Yield
91 89 97 99
Value
63 45 66 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
73 1 61 19
Profit Growth
63 27 43 31
Capital Growth
43 19 15 52
Stock Returns
75 49 85 93
Growth
87 8 47 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
72 59 59 36
Refinancing
59 60 65 69
Liquidity
58 44 55 30
Safety Safety
68 58 65 37

Similar Stocks

Discover high‑ranked alternatives to Apex Biotechnology and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Sumitomo Forestry

TSE:1911
Country: Japan
Industry: Homebuilding
Size: X-Large
Full Stock Analysis

Asustek Computer

TSEC:2357
Country: Taiwan
Industry: Technology Hardware & Peripherals
Size: Large
Full Stock Analysis

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis
OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.